Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:2367-2375
Published online before print April 20, 2009, doi: 10.1161/CIRCULATIONAHA.108.807537
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
119/17/2367    most recent
CIRCULATIONAHA.108.807537v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gautier, E. L.
Right arrow Articles by Lesnik, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gautier, E. L.
Right arrow Articles by Lesnik, P.
Related Collections
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Pathophysiology
Right arrow Growth factors/cytokines
Right arrow Lipid and lipoprotein metabolism
Right arrowRelated Article

(Circulation. 2009;119:2367-2375.)
© 2009 American Heart Association, Inc.


Vascular Medicine

Conventional Dendritic Cells at the Crossroads Between Immunity and Cholesterol Homeostasis in Atherosclerosis

Emmanuel L. Gautier, PhD; Thierry Huby, PhD; Flora Saint-Charles, MSc; Betty Ouzilleau, BS; John Pirault, MSc; Virginie Deswaerte, MSc; Florent Ginhoux, PhD; Elizabeth R. Miller, BS; Joseph L. Witztum, MD; M. John Chapman, PhD, DSc; Philippe Lesnik, PhD

From INSERM UMR-S 939, Hôpital de la Pitié (E.L.G., T.H., F.S.-C., B.O., J.P., V.D., M.J.C., P.L.), Paris, France; Université Pierre et Marie Curie, Université Paris 06, UMR-S 939 (E.L.G., T.H., F.S.-C., B.O., J.P., V.D., M.J.C., P.L.), Paris, France; Assistance Publique–Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Service d’Endocrinologie-Métabolisme (T.H., M.J.C., P.L.), Paris, France; Department of Medicine, University of California San Diego (E.R.M., J.L.W.), La Jolla, Calif; and Department of Gene and Cell Medicine and Department of Medicine, Mount Sinai School of Medicine (F.G.), New York, NY.

Correspondence to Dr Philippe Lesnik, INSERM U939, Hôpital de la Pitié, 83 Bd de l’hôpital, 75651 Paris 13, France. E-mail philippe.lesnik{at}upmc.fr

Received July 15, 2008; accepted March 6, 2009.

Background— Immunoinflammatory mechanisms are implicated in the atherogenic process. The polarization of the immune response and the nature of the immune cells involved, however, are major determinants of the net effect, which may be either proatherogenic or antiatherogenic. Dendritic cells (DCs) are central to the regulation of immunity, the polarization of the immune response, and the induction of tolerance to antigens. The potential role of DCs in atherosclerosis, however, remains to be defined.

Methods and Results— We created a mouse model in which the lifespan and immunogenicity of conventional DCs are enhanced by specific overexpression of the antiapoptotic gene hBcl-2 under the control of the CD11c promoter. When studied in either low-density lipoprotein receptor–deficient or apolipoprotein E–deficient backgrounds, DC-hBcl2 mice exhibited an expanded DC population associated with enhanced T-cell activation, a T-helper 1 and T-helper 17 cytokine expression profile, and elevated production of T-helper 1–driven IgG2c autoantibodies directed against oxidation-specific epitopes. This proatherogenic signature, however, was not associated with acceleration of atherosclerotic plaque progression, because expansion of the DC population was unexpectedly associated with an atheroprotective decrease in plasma cholesterol levels. Conversely, depletion of DCs in hyperlipidemic CD11c–diphtheria toxin receptor/apolipoprotein E–deficient transgenic mice resulted in enhanced cholesterolemia, thereby arguing for a close relationship between the DC population and plasma cholesterol levels.

Conclusions— Considered together, the present data reveal that conventional DCs are central to the atherosclerotic process, because they are directly implicated in both cholesterol homeostasis and the immune response.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 119: 2295-2296. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Circ. Res.Home page
K. E. Paulson, S.-N. Zhu, M. Chen, S. Nurmohamed, J. Jongstra-Bilen, and M. I. Cybulsky
Resident Intimal Dendritic Cells Accumulate Lipid and Contribute to the Initiation of Atherosclerosis
Circ. Res., February 5, 2010; 106(2): 383 - 390.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Billon-Gales, C. Fontaine, V. Douin-Echinard, L. Delpy, H. Berges, B. Calippe, F. Lenfant, H. Laurell, J.-C. Guery, P. Gourdy, et al.
Endothelial Estrogen Receptor-{alpha} Plays a Crucial Role in the Atheroprotective Action of 17{beta}-Estradiol in Low-Density Lipoprotein Receptor-Deficient Mice
Circulation, December 22, 2009; 120(25): 2567 - 2576.
[Abstract] [Full Text] [PDF]